Drug Patents owned by Tetraphase Pharms

1. Drug name - XERAVA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10961190 TETRAPHASE PHARMS Crystalline forms of eravacycline
Oct, 2037

(15 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8796245 TETRAPHASE PHARMS C7-fluoro substituted tetracycline compounds Aug, 2029

(6 years from now)

US8906887 TETRAPHASE PHARMS C7-fluoro substituted tetracycline compounds Dec, 2030

(8 years from now)

Drugs and Companies using ERAVACYCLINE DIHYDROCHLORIDE ingredient

Treatment: Treatment of complicated intra-abdominal infections in patients 18 years of age and older

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 50MG BASE/VIAL POWDER;INTRAVENOUS Prescription
EQ 100MG BASE/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.